142 related articles for article (PubMed ID: 38490902)
1. Premalignant Lesions in the Kidney Transplant Candidate.
Schroder PM; Biesterveld BE; Al-Adra DP
Semin Nephrol; 2024 Mar; ():151495. PubMed ID: 38490902
[TBL] [Abstract][Full Text] [Related]
2. A Review of the Diagnosis and Management of Premalignant Pancreatic Cystic Lesions.
Keane MG; Afghani E
J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33808853
[TBL] [Abstract][Full Text] [Related]
3. Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive Management.
El Gammal AT; Izbicki JR
Surg Clin North Am; 2018 Feb; 98(1):141-155. PubMed ID: 29191271
[TBL] [Abstract][Full Text] [Related]
4. Long-term (10-year) outcomes and prognostic factors in resected intraductal papillary mucinous neoplasm tumors in Finland: A nationwide retrospective study.
Vaalavuo Y; Vornanen M; Ahola R; Antila A; Rinta-Kiikka I; Sand J; Laukkarinen J
Surgery; 2023 Jul; 174(1):75-82. PubMed ID: 37062604
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
Srinivasan N; Koh YX; Goh BKP
Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
[TBL] [Abstract][Full Text] [Related]
6. Cystic pancreatic neoplasms: observe or operate.
Spinelli KS; Fromwiller TE; Daniel RA; Kiely JM; Nakeeb A; Komorowski RA; Wilson SD; Pitt HA
Ann Surg; 2004 May; 239(5):651-7; discussion 657-9. PubMed ID: 15082969
[TBL] [Abstract][Full Text] [Related]
7. An Appraisal of Current Guidelines for Managing Malignancy in Pancreatic Intraductal Papillary Mucinous Neoplasm.
Takakura K; Torisu Y; Kinoshita Y; Tomita Y; Nakano M; Oikawa T; Tsukinaga S; Sumiyama K; Eibl G; Saruta M
JOP; 2018 Jul; 19(4):178-182. PubMed ID: 30636939
[TBL] [Abstract][Full Text] [Related]
8. Enucleation: A treatment alternative for branch duct intraductal papillary mucinous neoplasms.
Kaiser J; Fritz S; Klauss M; Bergmann F; Hinz U; Strobel O; Schneider L; Büchler MW; Hackert T
Surgery; 2017 Mar; 161(3):602-610. PubMed ID: 27884612
[TBL] [Abstract][Full Text] [Related]
9. Senescence in intraductal papillary mucinous neoplasm of the pancreas.
Miyasaka Y; Nagai E; Ohuchida K; Fujita H; Nakata K; Hayashi A; Mizumoto K; Tsuneyoshi M; Tanaka M
Hum Pathol; 2011 Dec; 42(12):2010-7. PubMed ID: 21733551
[TBL] [Abstract][Full Text] [Related]
10. Intraductal papillary mucinous neoplasm and the pancreatic incidentaloma.
Kent TS; Vollmer CM; Callery MP
World J Gastrointest Surg; 2010 Oct; 2(10):319-23. PubMed ID: 21160837
[TBL] [Abstract][Full Text] [Related]
11. Surgical indication for intraductal papillary mucinous neoplasm without mural nodule ≥5 mm.
Tsumura A; Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yanagisawa A; Yamaue H
Surgery; 2021 Feb; 169(2):388-395. PubMed ID: 32859391
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical characteristics and malignant progression of hepatic cystic neoplasms in comparison with pancreatic counterparts.
Matsubara T; Sato Y; Sasaki M; Harada K; Nomoto K; Tsuneyama K; Nakamura K; Gabata T; Matsui O; Nakanuma Y
Hum Pathol; 2012 Dec; 43(12):2177-86. PubMed ID: 22705005
[TBL] [Abstract][Full Text] [Related]
13. Chronic immunosuppression does not potentiate the malignant progression of mucinous pancreatic cystic lesions.
Agarwal A; Scott FI; Ahmad NA; Chandrasekhara V
Pancreatology; 2016; 16(5):900-4. PubMed ID: 27424477
[TBL] [Abstract][Full Text] [Related]
14. Cytology from pancreatic cysts has marginal utility in surgical decision-making.
Maker AV; Lee LS; Raut CP; Clancy TE; Swanson RS
Ann Surg Oncol; 2008 Nov; 15(11):3187-92. PubMed ID: 18766406
[TBL] [Abstract][Full Text] [Related]
15. Concomitant intraductal papillary mucinous neoplasm and pancreatic endocrine tumour: Report of two cases and review of the literature.
Larghi A; Stobinski M; Galasso D; Lecca PG; Costamagna G
Dig Liver Dis; 2009 Oct; 41(10):759-61. PubMed ID: 19223252
[TBL] [Abstract][Full Text] [Related]
16. Mucin-producing neoplasms of the pancreas. Intraductal papillary and mucinous cystic neoplasms.
Shyr YM; Su CH; Tsay SH; Lui WY
Ann Surg; 1996 Feb; 223(2):141-6. PubMed ID: 8597507
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of non-invasive intraductal papillary municious neoplasm seven years following total pancreatectomy.
Dejean NM; Dumitra S; Barkun JS
Int J Surg Case Rep; 2013; 4(9):789-91. PubMed ID: 23891959
[TBL] [Abstract][Full Text] [Related]
18. Intraductal papillary mucinous neoplasms of the pancreas: Uncommon imaging presentation, evolution and comparison of guidelines.
Minelli C; Balducci F; Cavalleri C; Milanetto AC; Ferrara F; Crimì F; Quaia E; Vernuccio F
Eur J Radiol Open; 2023 Dec; 11():100531. PubMed ID: 37920680
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and therapeutic endoscopic approaches to intraductal papillary mucinous neoplasm.
Turner BG; Brugge WR
World J Gastrointest Surg; 2010 Oct; 2(10):337-41. PubMed ID: 21160840
[TBL] [Abstract][Full Text] [Related]
20. The Clinical and Socio-Economic Relevance of Increased IPMN Detection Rates and Management Choices.
Budde C; Beyer G; Kühn JP; Lerch MM; Mayerle J
Viszeralmedizin; 2015 Feb; 31(1):47-52. PubMed ID: 26286668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
